---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024110"
form_type: "8-K"
ticker: "LTRN"
cik: "0001763950"
company_name: "Lantern Pharma Inc."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:08:42.671660+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve all proposals at 2024 annual meeting

## Summary
- Five directors elected: Keyser, Sharma, Chandru, Maccecchini, Silberstein; each received ~3.04M votes for, ~22K withheld.
- Amendment to 2018 Equity Incentive Plan approved to increase share pool by 125,000 shares; 2.89M for, 128K against.
- Ratification of EisnerAmper LLP as independent auditor for FY2024 passed with 7.17M votes for, 40K against.
- Broker non-votes of 4.23M on director election and equity plan; no broker non-votes on auditor ratification.

## SEC filing metadata
- accession: 0001493152-24-024110
- form_type: 8-K
- ticker: LTRN
- cik: 0001763950
- company_name: Lantern Pharma Inc.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763950/000149315224024110/0001493152-24-024110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763950/000149315224024110/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024110
- JSON: https://secwatch.observer/filing/0001493152-24-024110.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024110.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.